GSK plc
F:GS70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GSK plc
F:GS70
|
UK |
|
Akobo Minerals AB (publ)
OTC:AKOBF
|
SE |
|
P
|
Psybio Therapeutics Corp
OTC:PSYBF
|
CA |
|
G
|
Gesco SE
DUS:GSC1
|
DE |
|
C
|
Crown Lifters Ltd
NSE:CROWN
|
IN |
|
T
|
Trip.com Group Ltd
F:CLV
|
SG |
|
E
|
Euronext Athens Holding SA
XMUN:HEE
|
GR |
|
P
|
Philip Morris CR as
XMUN:TBK
|
CZ |
|
Summa Defence Oyj
F:5J40
|
FI |
|
K
|
Korea No.12 Special Purpose Acquisition Co Ltd
KOSDAQ:458610
|
KR |
|
Sasseur Real Estate Investment Trust
SGX:CRPU
|
SG |
|
M
|
Medical Facilities Corp
OTC:MFCSF
|
CA |
|
S
|
Supercomnet Technologies Bhd
KLSE:SCOMNET
|
MY |
|
T
|
T&D Holdings Inc
F:TZ6
|
JP |
|
Solesence Inc
NASDAQ:SLSN
|
US |
|
K
|
KCG Corporation PCL
SET:KCG
|
TH |
|
C
|
CTS Eventim AG & Co KgaA
SWB:EVD
|
DE |
Bankruptcy Probability
GSK plc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GSK plc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
GSK plc
XETRA:GS71
|
84.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GSK plc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GSK plc has total debt of 13.9B GBP. This includes both short-term (0 GBP) and long-term (13.9B GBP) debt.
You can find a full breakdown on its Balance Sheet.